Peter M. Rothwell
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Neurology top 0.02%
- Intracranial Aneurysms: Treatment and Complications
- Traumatic Brain Injury and Neurovascular Disturbances
Papers in
- Epidemiology 290
- Acute Ischemic Stroke Management 287
-
- Cerebrovascular and Carotid Artery Diseases 239
- Co-authors
- Sarah T. Pendlebury (43 shared papers)Charles Warlow (31 shared papers)Ziyah Mehta (42 shared papers)Joanna Lovett (14 shared papers)Ursula G. Schulz (26 shared papers)Tom Meade (5 shared papers)Matthew F. Giles (16 shared papers)Linxin Li (67 shared papers)
- Journals
- Stroke (158 papers)Cerebrovascular Diseases (37 papers)The Lancet (30 papers)International Journal of Stroke (29 papers)The Lancet Neurology (26 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Peter M. Rothwell
537 papers receiving 44.4k citations
Peter M. Rothwell's Hit Papers
Peers
Comparison fields: 5 of 212
- Cardiology and Cardiovascular Medicine 16.4k
- Neurology 9.4k
- Internal Medicine 2.1k
- Rehabilitation 3.6k
- Pulmonary and Respiratory Medicine 17.1k
Countries citing papers authored by Peter M. Rothwell
This map shows the geographic impact of Peter M. Rothwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Rothwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Rothwell more than expected).
Fields of papers citing papers by Peter M. Rothwell
This network shows the impact of papers produced by Peter M. Rothwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Rothwell. The network helps show where Peter M. Rothwell may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter M. Rothwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 549 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | External validity of randomised controlled trials: “To whom do the results of this trial apply?” Hit paper breakdown → | 2005 | 1711 |
| 2 | Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis Hit paper breakdown → | 2009 | 1272 |
| 3 | Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Hit paper breakdown → | 2010 | 1251 |
| 4 | Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials Hit paper breakdown → | 2007 | 1100 |
| 5 | Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Hit paper breakdown → | 2010 | 1090 |
| 6 | Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Hit paper breakdown → | 2010 | 990 |
| 7 | Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack Hit paper breakdown → | 2007 | 874 |
| 8 | Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison Hit paper breakdown → | 2007 | 805 |
| 9 | Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Hit paper breakdown → | 2012 | 736 |
| 10 | Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Hit paper breakdown → | 2005 | 654 |
| 11 | Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Hit paper breakdown → | 2012 | 628 |
| 12 | Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials Hit paper breakdown → | 2012 | 627 |
| 13 | Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services Hit paper breakdown → | 2004 | 569 |
| 14 | Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis Hit paper breakdown → | 2010 | 547 |
| 15 | Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies Hit paper breakdown → | 2004 | 535 |
| 16 | Population-Based Study of Incidence and Outcome of Acute Aortic Dissection and Premorbid Risk Factor Control Hit paper breakdown → | 2013 | 522 |
| 17 | Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension Hit paper breakdown → | 2010 | 521 |
| 18 | Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2018 | 515 |
| 19 | Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke Hit paper breakdown → | 2010 | 480 |
| 20 | 2007 | 471 |
About Peter M. Rothwell
Peter M. Rothwell is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Neurology and Surgery, having authored 549 papers that have together received 45.8k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (287 papers), Cerebrovascular and Carotid Artery Diseases (239 papers), Cardiovascular Health and Disease Prevention (116 papers), Intracranial Aneurysms: Treatment and Complications (70 papers), Blood Pressure and Hypertension Studies (61 papers), Antiplatelet Therapy and Cardiovascular Diseases (40 papers), Venous Thromboembolism Diagnosis and Management (33 papers) and Health Systems, Economic Evaluations, Quality of Life (32 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (16.4k citations), Neurology (9.4k citations), Internal Medicine (2.1k citations), Rehabilitation (3.6k citations) and Pulmonary and Respiratory Medicine (17.1k citations). Peter M. Rothwell has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sarah T. Pendlebury, Charles Warlow, Ziyah Mehta, Joanna Lovett, Ursula G. Schulz, Tom Meade, Matthew F. Giles, Linxin Li, Kittipan Rerkasem and J. J. F. Belch. Their work appears in journals such as Stroke, Cerebrovascular Diseases, The Lancet, International Journal of Stroke and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.